Indication
Low-grade serous ovarian cancer
1 clinical trial
1 product
2 drugs
Clinical trial
Combination Targeted and Hormonal treAtMEnt of Low-gradE Serous Ovarian Cancer in the upfroNt SettingStatus: Recruiting, Estimated PCD: 2027-04-01
Drug
AvutometinibDrug
DefactinibProduct
Letrozole